A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort. Issue 1 (14th February 2023)

• Record Type: Journal Article
• Authors: Ugarte-Gil, Manuel Francisco; Gamboa-Cardenas, Rocio Violeta; Reátegui-Sokolova, Cristina; Pimentel-Quiroz, Victor Román; Medina, Mariela; Elera-Fitzcarrald, Claudia; Rodriguez-Bellido, Zoila; Pastor-Asurza, Cesar Augusto; Perich-Campos, Risto Alfredo; Alarcón, Graciela S
• Is Part Of: Lupus science & medicine. Volume 10:Issue 1(2023)
• Publication Date: 2023-02-14
• Subjects: lupus erythematosus, systemic -- quality of lIfe -- outcome assessment, health care; Systemic lupus erythematosus -- Periodicals; 616.772005
• DOI: 10.1136/lupus-2022-000874
• Languages: English
• ISSNs: 2398-8851

Abstract

Abstract : Objective: To determine the possible predictive value of self-efficacy on health-related quality of life (HRQoL) in patients with SLE. Methods: Patients with SLE from the Almenara Lupus Cohort were included. Self-efficacy was ascertained with the six domains from the Patient-Reported Outcomes Measurement Information System (PROMIS) self-efficacy for managing chronic conditions. For PROMIS domains, a score of 50 is the average for a clinical population (people with a chronic condition), a higher score indicates that the respondent has greater self-efficacy. HRQoL was ascertained with the physical and mental component summary (PCS and MCS) measures of the Short-Form 36 (SF-36). Generalised estimating equations were performed, using as outcome the PCS or MCS in the subsequent visit, and the self-efficacy domain in the previous visit; multivariable models were adjusted for possible confounders. The confounders were measured in the same visit as the self-efficacy domain. Results: Two-hundred and nine patients for a total of 564 visits were included; 194 (92.8%) patients were women and mean age at diagnosis was 36.4 (14.0) years. In the multivariable models, a better PCS was predicted by a better self-efficacy for managing symptoms, managing medications and treatments and managing social interactions and general self-efficacy; a better MCS was predicted by a better self-efficacy for managing daily activities, managing symptoms, managing medications and treatments and managing social interactions. Conclusion: A better self-efficacy is predictive of subsequent better HRQoL, even after adjustment for possible confounders. These results should encourage clinicians to develop strategies to improve self-efficacy in patients with SLE.